Warning letter
BioDevelopment Associates, LLC: warning letter of Jul 2, 2004
FDA warning letter UCM146869 · Center for Devices and Radiological Health
Key facts
| Reference number | UCM146869 |
|---|---|
| Company | BioDevelopment Associates, LLC |
| Subject | Good Laboratory Practices |
| Issue date | Jul 2, 2004 |
| Posted date | Jul 2, 2004 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 58.185(a)(13), 58, 58.35, 58.185, 58.29(a), 58.35(a), 58.35(b)(1), 58.35(b)(5), 58.35(b)(6), 58.185(a)(5) |
| Country | 3 |
| Inspection city | Mountlake Terrace |
| Inspection ZIP | 98043-3137 |
| Inspection start date | Nov 10, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: